Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer

Journal of Medical Screening

Volumn 11, Issue 3, 2004, Pages 130-134

  Dillon, M F ^a   Hill, A D K ^a,b,c   Quinn, C M ^a,b   O'Doherty, A ^a,b   Crown, J ^a   Fleming, F J ^a   McDermott, E W ^a,b,c   O'Higgins, N ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BreastCheck   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TUMOR BIOPSY; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MASS SCREENING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY;

EID: 4644342323     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/0969141041732238     Document Type: Article

References (29)

1. Solin LJ, Legoretta A, Schultz DJ. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. Arch Intern Med 1994;154:745-51
2. Groenenendijk RPR, Horst H, Tinnemans JGM, et al. Critical analysis of the treatment of non-palpable breast cancer: towards a less invasive future. World J Surg 2002;26:285-9
3. Roberts MM, Alexander FE, Anderson JT, et al. Edinburgh Trial of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-6
4. Norden T, Thurfjell E, Hasselgren M, et al. Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer 1997;33(4):624-8
5. Manecksha R, Hill AD, Dijksfra B, et al. Value of sentinel node biopsy in the management of breast cancer. Ir J Med Sci 2001;170(4):233-5
6. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2
7. Moritz S, Bates T, Henderson M, et al. Variation in management of small invasive breast cancers detected on screening in the former South East Thames region: observational study. BMJ 1997;315:1266-72
8. Andersson I, Aspegren K, Janson L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297:943-8
9. Ciatto S, Del Turco MR, Bonardi R, et al. Non-palpable lesions of the breast detected by mammography - review of 1182 consecutive histologically confirmed cases. Eur J Cancer 1994;30A(1):40-4
10. Tinnemans JGM, Wobbes T, Holland R, et al. Treatment and survival of female patients with nonpalpable breast carcinoma. Ann Surg 1989;209(2):249-53
11. Radford DM, Cromack DT, Troop BR, et al. Pathology and treatment of impalpable breast lesions. Am J Surg 1992;164:427-32
12. Spillane AJ, Kennedy CW, Gillett DJ, et al. Screen-detected cancer compared to symptomatic presentation: an analysis of surgical treatment and end-points of effective mammographic screening. ANZ J Surg 2001;71:398-402
13. Freedman GM, Anderson PR, Goldstein LJ, et al. Routine mammography is associated with earlier stage disease and greater eligibility for breast-conservation in breast carcinoma patients age 40 years and older. Cancer 2003;88(5):918-25
14. 2002 Annual Report, BreastCheck. Government publication.
15. de Konig HJ, Van Oortmarssen GJ, van Ineveld BM, et al. Breast cancer screening: its impact on clinical medicine. Br J Cancer 1990;61:292-7.
16. Mullan MH, Kissen MW. Breast screening and screen-detected disease. In: Farndon JR (ed). Breast Surgery, 2nd Edition - A Companion to Specialist Surgical Practice. London: W.B. Saunders Ltd 2001: 36
17. Chadha M, Chabon AB, Friedmann P, et al. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 1994;73:350-3
18. Walls J, Boggis CRM, Wilson M, et al. Treatment of the axilla in patients with screen-defected breast cancer. Br J Surg 1993;80:436-8
19. Mustafa IA, Cole B, Wanebo HJ, et al. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997;132:384-9
20. Mailbenco DC, Weiss LK, Pawlish KS, et al. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 1999;85(7):1530-6
21. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer. Arch Sura 1996;131:301-8
22. Olivotto IA, Jackson JSH, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer 1998;83(5):948-55
23. Silverstein MJ, Skinner KA, Lomis TJ. Predicting nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767-72
24. Gann PH, Colilla SA, Gapstur SM, et al. Factors associated with axillary lymph node metastasis from breast carcinoma. Cancer 1999;86:1511-9
25. Klemi PJ, Joensuu H, Toikkanen S, et al. Aggressiveness of breast cancers found with or without screening. BMJ 1992;304:467-9
26. Heimann R, Munsell M, Mc Bride R. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just tumour size? Cancer J 2002;8(3):276-81
27. Holland PA, Walls J, Boggis CR, et al. A comparison of axillary node status between cancers detected at the prevalence and first incidence screening rounds. Br J Cancer 1996;74(10):1643-6
28. Tabar L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma. Cancer 1999;86:449-62
29. Wazer DE, Gage I, Homer MJ. Age- related differences in patients with non-palpable breast carcinomas. Cancer 1996;78:1432-7